突发公告！董事长被立案调查

Core Viewpoint - The company, Yong'an Pharmaceutical, is currently facing a significant event as its actual controller and chairman, Chen Yong, has been placed under investigation and detention by the local authorities, which may impact the company's governance and operations [1][5]. Group 1: Company Background and Structure - Yong'an Pharmaceutical was established in 2001 and went public in March 2010. The company primarily engages in three business segments: research, production, and sales of taurine products; health food; and special dietary foods (creatine) [5]. - The company has a well-established governance structure and internal control mechanisms, ensuring compliance with relevant laws and regulations [5]. Group 2: Recent Financial Performance - In the first quarter of the year, the company reported revenue of 171 million yuan, a year-on-year decrease of 12.96%. The net loss attributable to the parent company was 4.37 million yuan, a decline of 115.23% compared to the previous year [5]. Group 3: Stock Market Activity - Prior to the May Day holiday, Yong'an Pharmaceutical's stock experienced significant volatility, achieving five consecutive daily price increases from April 21 to April 29, with a total increase of nearly 60% during this period [4][5]. - On April 30, the stock closed at a limit down price of 12.91 yuan per share, with a market capitalization of 3.8 billion yuan [6].